Sionna Therapeutics Stock Forward View - Polynomial Regression
| SION Stock | 36.11 0.86 2.44% |
Sionna Stock outlook is based on your current time horizon. Although Sionna Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Sionna Therapeutics' systematic risk associated with finding meaningful patterns of Sionna Therapeutics fundamentals over time.
As of today the rsi of Sionna Therapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (2.03) | EPS Estimate Next Year (2.14) | Wall Street Target Price 44.8571 | EPS Estimate Current Quarter (0.47) |
Using Sionna Therapeutics hype-based prediction, you can estimate the value of Sionna Therapeutics Common from the perspective of Sionna Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Sionna Relative Strength Index
The Polynomial Regression forecasted value of Sionna Therapeutics Common on the next trading day is expected to be 40.51 with a mean absolute deviation of 1.86 and the sum of the absolute errors of 115.15.Sionna Therapeutics Hype to Price Pattern
Investor biases related to Sionna Therapeutics' public news can be used to forecast risks associated with an investment in Sionna. The trend in average sentiment can be used to explain how an investor holding Sionna can time the market purely based on public headlines and social activities around Sionna Therapeutics Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Sionna Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Sionna Therapeutics.
The Polynomial Regression forecasted value of Sionna Therapeutics Common on the next trading day is expected to be 40.51 with a mean absolute deviation of 1.86 and the sum of the absolute errors of 115.15. Sionna Therapeutics after-hype prediction price | USD 36.39 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sionna Therapeutics to cross-verify your projections. Sionna Therapeutics Additional Predictive Modules
Most predictive techniques to examine Sionna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sionna using various technical indicators. When you analyze Sionna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sionna Therapeutics Polynomial Regression Price Forecast For the 8th of February
Given 90 days horizon, the Polynomial Regression forecasted value of Sionna Therapeutics Common on the next trading day is expected to be 40.51 with a mean absolute deviation of 1.86, mean absolute percentage error of 5.20, and the sum of the absolute errors of 115.15.Please note that although there have been many attempts to predict Sionna Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sionna Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sionna Therapeutics Stock Forecast Pattern
| Backtest Sionna Therapeutics | Sionna Therapeutics Price Prediction | Research Analysis |
Sionna Therapeutics Forecasted Value
In the context of forecasting Sionna Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sionna Therapeutics' downside and upside margins for the forecasting period are 35.26 and 45.77, respectively. We have considered Sionna Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Sionna Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sionna Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.5969 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.8572 |
| MAPE | Mean absolute percentage error | 0.0462 |
| SAE | Sum of the absolute errors | 115.149 |
Predictive Modules for Sionna Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sionna Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sionna Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Sionna Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sionna Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sionna Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sionna Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Sionna Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sionna Therapeutics' historical news coverage. Sionna Therapeutics' after-hype downside and upside margins for the prediction period are 31.13 and 41.65, respectively. We have considered Sionna Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sionna Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Sionna Therapeutics is based on 3 months time horizon.
Sionna Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sionna Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sionna Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sionna Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 5.26 | 0.28 | 0.03 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
36.11 | 36.39 | 0.78 |
|
Sionna Therapeutics Hype Timeline
Sionna Therapeutics is at this time traded for 36.11. The entity has historical hype elasticity of 0.28, and average elasticity to hype of competition of 0.03. Sionna is estimated to increase in value after the next headline, with the price projected to jump to 36.39 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.78%, whereas the daily expected return is at this time at 0.15%. The volatility of related hype on Sionna Therapeutics is about 2348.21%, with the expected price after the next announcement by competition of 36.14. Net Loss for the year was (61.69 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next estimated press release will be in about 10 days. Check out Historical Fundamental Analysis of Sionna Therapeutics to cross-verify your projections.Sionna Therapeutics Related Hype Analysis
Having access to credible news sources related to Sionna Therapeutics' direct competition is more important than ever and may enhance your ability to predict Sionna Therapeutics' future price movements. Getting to know how Sionna Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sionna Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| JANX | Janux Therapeutics | 0.1 | 8 per month | 0.00 | (0.10) | 7.88 | (5.30) | 63.52 | |
| ABCL | Abcellera Biologics | (0.04) | 11 per month | 0.00 | (0.15) | 6.33 | (8.82) | 28.69 | |
| MAZE | Maze Therapeutics Common | 2.06 | 7 per month | 2.99 | 0.12 | 6.77 | (4.83) | 20.03 | |
| BHVN | Biohaven Pharmaceutical Holding | (0.87) | 9 per month | 0.00 | (0.02) | 10.23 | (7.08) | 40.22 | |
| CLDX | Celldex Therapeutics | (0.1) | 6 per month | 0.00 | (0.03) | 6.44 | (5.57) | 14.68 | |
| VERA | Vera Therapeutics | 3.01 | 11 per month | 2.77 | 0.17 | 10.77 | (4.40) | 23.44 | |
| XERS | Xeris Pharmaceuticals | (0.53) | 10 per month | 0.00 | (0.13) | 4.71 | (4.66) | 21.88 | |
| ZYME | Zymeworks Common Stock | (1.14) | 7 per month | 2.87 | 0.05 | 5.40 | (4.72) | 36.09 | |
| ARDX | Ardelyx | 0.20 | 9 per month | 3.10 | 0.05 | 8.50 | (5.04) | 24.98 | |
| IMNM | Immunome | (0.45) | 11 per month | 4.13 | 0.12 | 7.87 | (6.71) | 31.45 |
Other Forecasting Options for Sionna Therapeutics
For every potential investor in Sionna, whether a beginner or expert, Sionna Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sionna Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sionna. Basic forecasting techniques help filter out the noise by identifying Sionna Therapeutics' price trends.Sionna Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sionna Therapeutics stock to make a market-neutral strategy. Peer analysis of Sionna Therapeutics could also be used in its relative valuation, which is a method of valuing Sionna Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sionna Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Sionna Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sionna Therapeutics shares will generate the highest return on investment. By undertsting and applying Sionna Therapeutics stock market strength indicators, traders can identify Sionna Therapeutics Common entry and exit signals to maximize returns.
| Accumulation Distribution | 37737.18 | |||
| Daily Balance Of Power | 0.2583 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 36.53 | |||
| Day Typical Price | 36.39 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.86 |
Sionna Therapeutics Risk Indicators
The analysis of Sionna Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sionna Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sionna stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.26 | |||
| Semi Deviation | 5.36 | |||
| Standard Deviation | 5.08 | |||
| Variance | 25.77 | |||
| Downside Variance | 32.07 | |||
| Semi Variance | 28.73 | |||
| Expected Short fall | (3.04) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Sionna Therapeutics
The number of cover stories for Sionna Therapeutics depends on current market conditions and Sionna Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sionna Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sionna Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sionna Therapeutics Short Properties
Sionna Therapeutics' future price predictability will typically decrease when Sionna Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sionna Therapeutics Common often depends not only on the future outlook of the potential Sionna Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sionna Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.1 M | |
| Cash And Short Term Investments | 147.5 M |
Check out Historical Fundamental Analysis of Sionna Therapeutics to cross-verify your projections. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Will Biotechnology sector continue expanding? Could Sionna diversify its offerings? Factors like these will boost the valuation of Sionna Therapeutics. If investors know Sionna will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sionna Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Sionna Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sionna Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Sionna Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sionna Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sionna Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sionna Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.